What is the clinical evidence from this study?

Study design: Review. Population: Takotsubo syndrome and non-ischemic cardiomyopathy.

What does this research mean for the field?

The occurrence of Takotsubo syndrome in patients with pre-existing non-ischemic cardiomyopathy is driven by complex pathophysiological mechanisms including supraphysiological catecholamine surge, biased β-adrenergic receptor signaling, inflammatory sensitization, and mitochondrial dysfunction. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

This review aims to explore the mechanisms and clinical implications of Takotsubo syndrome in patients with pre-existing non-ischemic cardiomyopathy.

April 15, 2026

Takotsubo syndrome in the context of pre-existing non-ischemic cardiomyopathy: mechanistic and clinical implications

Key Result

This review highlights the pathophysiological mechanisms of Takotsubo syndrome in non-ischemic cardiomyopathy, including catecholamine surge, inflammatory sensitization, and mitochondrial dysfunction.

Key Points

This review aims to explore the mechanisms and clinical implications of Takotsubo syndrome in patients with pre-existing non-ischemic cardiomyopathy.
Comprehensive literature review
Analysis of pathophysiological mechanisms
Discussion of catecholamine surge and receptor signaling
Identified supraphysiological catecholamine surge as a key factor
Highlighted biased β-adrenergic receptor signaling's role
Discussed inflammatory-mediated sensitization and mitochondrial dysfunction influences

Structured PICO

Population

Patients with established non-ischemic cardiomyopathy (NICMP) who develop Takotsubo syndrome (TTS)

This review highlights the pathophysiological mechanisms of Takotsubo syndrome occurring in patients with pre-existing non-ischemic cardiomyopathy, challenging the classical understanding of TTS.

Abstract

Takotsubo syndrome (TTS), a transient left ventricular (LV) dysfunction typically precipitated by acute emotional or physical stress, is classically observed in individuals with structurally normal hearts. However, its occurrence in patients with established non-ischemic cardiomyopathy (NICMP) represents a striking clinical paradox that challenges our current understanding of both disease entities. This comprehensive review examines the complex pathophysiological mechanisms underlying this phenomenon, with particular emphasis on supraphysiological catecholamine surge and biased β-adrenergic receptor signaling, inflammatory-mediated sensitization, intrinsic mitochondrial dysfunction and mechanically-induced cytokine amplification.

Bookmark